Tekla Healthcare Investors HQH
We take great care to ensure that the data presented and summarized in this overview for TEKLA HEALTHCARE INVESTORS is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding HQH
View all-
Morgan Stanley New York, NY3.35MShares$56.8 Million0.0% of portfolio
-
Saba Capital Management, L.P. New York, NY2.87MShares$48.7 Million1.14% of portfolio
-
Penserra Capital Management LLC Orinda, CA867KShares$14.7 Million0.35% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL435KShares$7.38 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A6431KShares$7.31 Million0.0% of portfolio
-
Raymond James & Associates St Petersburg, FL355KShares$6.03 Million0.0% of portfolio
-
Aqr Arbitrage LLC Greenwich, CT267KShares$4.52 Million0.24% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN261KShares$4.42 Million0.0% of portfolio
-
Needham Investment Management LLC New York, NY255KShares$4.33 Million0.39% of portfolio
-
Sage Capital Management, LLC Stockton, NJ204KShares$3.46 Million1.82% of portfolio
Latest Institutional Activity in HQH
Top Purchases
Top Sells
About HQH
Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Insider Transactions at HQH
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 16
2024
|
Rose Di Martino Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$18,000
$18.88 P/Share
|
Apr 09
2024
|
Kathleen Goetz Director |
BUY
Open market or private purchase
|
Direct |
525
+32.73%
|
$8,400
$16.42 P/Share
|
Jan 02
2024
|
Todd Reit Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$16,000
$16.93 P/Share
|
Dec 28
2023
|
Bill Maher Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$16,000
$16.58 P/Share
|
Dec 21
2023
|
Alan R Goodson Vice President |
BUY
Open market or private purchase
|
Direct |
170
+50.0%
|
$2,720
$16.13 P/Share
|
Sep 25
2023
|
Daniel R Omstead President |
BUY
Open market or private purchase
|
Direct |
9,500
+5.06%
|
$142,500
$15.63 P/Share
|
Sep 20
2023
|
Daniel R Omstead President |
BUY
Open market or private purchase
|
Direct |
9,500
+5.33%
|
$142,500
$15.88 P/Share
|
Mar 23
2022
|
Kathleen Goetz Director |
BUY
Open market or private purchase
|
Direct |
73
+11.64%
|
$1,460
$20.42 P/Share
|
Jan 26
2022
|
Kathleen Goetz Director |
BUY
Open market or private purchase
|
Direct |
481
+50.0%
|
$10,101
$21.52 P/Share
|
Oct 26
2020
|
Daniel R Omstead President |
BUY
Open market or private purchase
|
Direct |
5,200
+3.98%
|
$104,000
$20.53 P/Share
|
Oct 21
2020
|
Daniel R Omstead President |
BUY
Open market or private purchase
|
Direct |
5,050
+4.03%
|
$101,000
$20.68 P/Share
|
Last 12 Months Summary
Open market or private purchase | 3.7K shares |
---|